首页> 外文期刊>The Journal of Thoracic and Cardiovascular Surgery >Long-term survival and prognostic factors of five-year survivors with complete resection of non-small cell lung carcinoma.
【24h】

Long-term survival and prognostic factors of five-year survivors with complete resection of non-small cell lung carcinoma.

机译:完全切除非小细胞肺癌的五年生存者的长期生存和预后因素。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: We analyzed the long-term follow-up data on cancer-related death in 5-year survivors of complete resection of their non-small cell lung cancer and examined the prognostic factors having an impact on subsequent survival. METHODS: Of 848 consecutive patients with proven primary non-small cell carcinoma who underwent complete removal of the primary tumor together with hilar and mediastinal lymph nodes, 421 patients (49.6%) survived 5 years or longer after the initial surgical treatment. Of all the data analyzed, only death related to cancer was treated as death. RESULTS: The median follow-up of 5-year survivors was 84 months from the original treatment (range, 60 to 200 months). Their overall survival rate at 10 years was 91.0%. Multivariable Cox analysis demonstrated that although advanced surgical-pathological stage (P =.0001), nodal involvement (P =.0245), male gender (P =.0313), and non-squamous type of the tumor (P =.0034) were significant, independent, unfavorable prognostic determinants in all patients, none of the variables investigated significantly influenced the long-term survival of 5-year survivors. The rate of recurrence beyond 5 years was much lower compared with that within 5 years. In contrast, the rate of occurrence of new malignancies was unchanged throughout the long-term postoperative period. CONCLUSIONS: Among 5-year survivors of complete resection of non-small cell lung cancer, neither stage, nodal status, sex, nor histologic condition further affected subsequent survival, suggesting that the 5-year interval might be sufficient to declare that a patient with lung cancer has been cured.
机译:目的:我们分析了5年完全切除非小细胞肺癌幸存者的癌症相关死亡的长期随访资料,并检查了影响其后续生存的预后因素。方法:在848例经证实的原发性非小细胞癌患者中,已完全切除原发性肿瘤并伴有肺门和纵隔淋巴结转移,其中421例患者(49.6%)在初次手术治疗后生存了5年或更长时间。在所有分析数据中,只有与癌症相关的死亡被视为死亡。结果:5年生存者的中位随访期为原始治疗的84个月(范围为60到200个月)。他们的10年总生存率为91.0%。多变量Cox分析表明,尽管手术病理分期(P = .0001),淋巴结受累(P = .0245),男性(P = .0313)和非鳞状肿瘤(P = .0034)在所有患者中都是重要的,独立的,不利的预后决定因素,所调查的变量均未显着影响5年生存者的长期生存。 5年以上的复发率远低于5年。相反,在长期的术后期间,新恶性肿瘤的发生率没有变化。结论:在完全切除非小细胞肺癌的5年幸存者中,分期,淋巴结状态,性别或组织学状况均未进一步影响随后的生存,表明5年间期可能足以宣布患有小细胞肺癌的患者。肺癌已经治愈。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号